Literature DB >> 34566308

Endometrial Stromal Sarcoma, an Unusual Recurrence: A Case Report.

Aswathy G Nath1, Sambasivan Suchetha1, Prabhakaran Nair Rema1, Jayapalan Sivarenjith2, Elizabeth Reshmi John2, Rari P Mony3.   

Abstract

Entities:  

Year:  2021        PMID： 34566308      PMCID： PMC8418570          DOI： 10.1007/s13224-021-01442-9

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


× No keyword cloud information.
  17 in total

1.  Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma.

Authors:  Lisa A Dos Santos; Karuna Garg; John P Diaz; Robert A Soslow; Martee L Hensley; Kaled M Alektiar; Richard R Barakat; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2011-01-26       Impact factor: 5.482

2.  Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma.

Authors:  Mario M Leitao; Murray F Brennan; Martee Hensley; Yukio Sonoda; Amanda Hummer; Dharmendra Bhaskaran; Ennapadam Venkatraman; Kaled Alektiar; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2002-12       Impact factor: 5.482

3.  Frequency of known gene rearrangements in endometrial stromal tumors.

Authors:  Sarah Chiang; Rola Ali; Nataliya Melnyk; Jessica N McAlpine; David G Huntsman; C Blake Gilks; Cheng-Han Lee; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2011-09       Impact factor: 6.394

4.  Lymph node metastases in low-grade endometrial stromal sarcoma.

Authors:  J Riopel; M Plante; M-C Renaud; M Roy; B Têtu
Journal:  Gynecol Oncol       Date:  2005-02       Impact factor: 5.482

5.  Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.

Authors:  Robert L Giuntoli; Elizabeth Garrett-Mayer; Robert E Bristow; Bobbie S Gostout
Journal:  Gynecol Oncol       Date:  2007-04-16       Impact factor: 5.482

6.  A multi-institutional review of outcomes of endometrial stromal sarcoma.

Authors:  Charles A Leath; Warner K Huh; Johnny Hyde; David E Cohn; Kimberly E Resnick; Nicholas P Taylor; Matthew A Powell; David G Mutch; William H Bradley; Melissa A Geller; Peter A Argenta; Michael A Gold
Journal:  Gynecol Oncol       Date:  2007-02-23       Impact factor: 5.482

7.  Treatment of endometrial stromal tumors.

Authors:  A Berchuck; S C Rubin; W J Hoskins; P E Saigo; V K Pierce; J L Lewis
Journal:  Gynecol Oncol       Date:  1990-01       Impact factor: 5.482

8.  Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.

Authors:  Jay P Shah; Christopher S Bryant; Sanjeev Kumar; Rouba Ali-Fehmi; John M Malone; Robert T Morris
Journal:  Obstet Gynecol       Date:  2008-11       Impact factor: 7.661

9.  Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.

Authors:  Jeong-Yeol Park; Min-Hyun Baek; Yangsoon Park; Young-Tak Kim; Joo-Hyun Nam
Journal:  Virchows Arch       Date:  2018-06-04       Impact factor: 4.064

10.  The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.

Authors:  Xianyong Ma; Jinglan Wang; Jianhui Wang; Charles X Ma; Xiaobin Gao; Vytas Patriub; Jeffrey L Sklar
Journal:  Oncotarget       Date:  2017-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.